Other
CYCLOPROPYLBIMATOPROST
Safety score · 0–100
Avoid
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
A close cousin of the prescription glaucoma drug bimatoprost. Used illegally in some lash serums; can darken iris, sink eyelids, and cause periorbital fat loss.
Function
Skin benefits
- No legitimate cosmetic benefit
Known concerns
- Prostaglandin analog drug, not a cosmetic
- Same class as bimatoprost (Latisse) prescription only
- Eye risks: iris pigmentation change, periorbital fat loss, eyelid darkening
- Not approved for OTC cosmetic use in EU
- Adulteration concern in lash serums
References
EU CosIng database
European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.
Related others
Check your shelf
Find CYCLOPROPYLBIMATOPROST in your products.
Scan any cosmetic product with LuxSense to see if it contains CYCLOPROPYLBIMATOPROST and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.